Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999655 | Urologic Oncology: Seminars and Original Investigations | 2015 | 7 Pages |
Abstract
The phosphorylation status of 4E-BP1 appeared to be correlated with the prognosis of patients with muscle-invasive BC following radical cystectomy as well as the sensitivities of BC cells to mTOR inhibitors; therefore, the inactivation of 4E-BP1 using Ku-0063794 may be a promising novel approach for muscle-invasive BC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Masatomo M.D., Ph.D., Hideaki M.D., Ph.D., Hosny M. M.D., Ph.D., Masato M.D., Ph.D.,